Actuation‐Mediated Compression of a Mechanoresponsive Hydrogel by Soft Robotics to Control Release of Therapeutic Proteins
Authors:
- Eimear J. WallaceEWEimear J. Wallace
- Joanne O'DWyerJOJoanne O'DWyer
- Eimear B. DolanEDEimear B. Dolan
- Liam P. BurkeLBLiam P. Burke
- Robert WylieRWRobert Wylie
- Gabriella BellaviaGBGabriella Bellavia
- Francesca CianfaraniFCFrancesca Cianfarani
- Simona SeriniSSSimona Serini
- Gabriella CalvielloGCGabriella Calviello
- Ellen T. RocheEREllen T. Roche
Open Access
- 18 December 2024
- journal article
- research article
- Published by Wiley in Advanced Science
- Vol. 12 (7) , e2401744
Abstract
Therapeutic proteins, the fastest growing class of pharmaceuticals, are subject to rapid proteolytic degradation in vivo, rendering them inactive. Sophisticated drug delivery systems that maintain protein stability, prolong therapeutic effects, and reduce administration frequency are urgently required. Herein, a mechanoresponsive hydrogel is developed contained within a soft robotic drug delivery (SRDD) device. In a step‐change from previously reported systems, pneumatic actuation of this system releases the cationic therapeutic protein Vascular Endothelial Growth Factor (VEGF) in a bioactive form which is required for therapeutic angiogenesis, the growth of new blood vessels, in numerous clinical conditions. The ability of the SRDD device to release bioactive VEGF in a spatiotemporal manner from the hydrogel is tested in diabetic rats – a model in which angiogenesis is difficult to stimulate. Daily actuation of the SRDD device in the diabetic rat model significantly increased cluster of differentiation 31+ (CD31+) blood vessel number (p = 0.0335) and the diameter of alpha‐smooth muscle actin+ (α‐SMA+) blood vessels (p = 0.0025) compared to passive release of VEGF from non‐actuated devices. The SRDD device combined with the mechanoresponsive hydrogel offers the potential to deliver an array of bioactive therapeutics in a spatiotemporal manner to mimic their natural release in vivo.Keywords
Funding Information
- Horizon 2020 Framework Programme (713690, 812865)
- Irish Research Council (GOIPD/2020/157)
- Science Foundation Ireland (13/RC/2073)
This publication has 88 references indexed in Scilit:
- Mechanoresponsive Drug Release from a Flexible, Tissue‐Adherent, Hybrid Hydrogel ActuatorAdvanced Materials, 2023
- Additive Manufacturing of Multi‐Scale Porous Soft Tissue Implants That Encourage Vascularization and Tissue IngrowthAdvanced Healthcare Materials, 2021
- Specialty Tough Hydrogels and Their Biomedical ApplicationsAdvanced Healthcare Materials, 2019
- Highly Elastic and Ultratough Hybrid Ionic–Covalent Hydrogels with Tunable Structures and MechanicsAdvanced Materials, 2018
- Bioinspired Nanocomposite Hydrogels with Highly Ordered StructuresAdvanced Materials, 2017
- Supertough Hybrid Hydrogels Consisting of a Polymer Double‐Network and Mesoporous Silica Microrods for Mechanically Stimulated On‐Demand Drug DeliveryAdvanced Functional Materials, 2017
- Soft Robotics: Review of Fluid‐Driven Intrinsically Soft Devices; Manufacturing, Sensing, Control, and Applications in Human‐Robot InteractionAdvanced Engineering Materials, 2017
- Self‐Healing HydrogelsAdvanced Materials, 2016
- Injectable and Cytocompatible Tough Double‐Network Hydrogels through Tandem Supramolecular and Covalent CrosslinkingAdvanced Materials, 2016
- Cell Interactions with Vascular Regenerative MAA‐Based Materials in the Context of Wound HealingAdvanced Healthcare Materials, 2015